[Thirty years of Met receptor research: from the discovery of an oncogene to the development of targeted therapies].

Med Sci (Paris) 2014 Oct 14;30(10):864-73. Epub 2014 Oct 14.

CNRS UMR 8161, Institut de biologie de Lille, Institut Pasteur de Lille, université de Lille 1 et 2, SIRIC ONCOLille, IFR142, 1, rue du Professeur Calmette, 59021 Lille, France.

In 1984, the Met receptor and its ligand, the HGF/SF, were discovered thanks to their ability to induce cell transformation and proliferation. Thirty years of research highlighted their crucial role in the development and homeostasis of various structures, including many epithelial organs. This period also allowed unraveling the structural basis of their interaction and their complex signaling network. In parallel, Met was shown to be deregulated and associated with a poor prognosis in many cancers. Met involvement in resistance to current therapies is also being deciphered. Based on these data, pharmaceutical companies developed a variety of Met inhibitors, some of which are evaluated in phase III clinical trials. In this review, we trace the exemplary track record of research on Met receptor, which allowed moving from bench to bedside through the development of therapies targeting its activity. Many questions still remain unanswered such as the involvement of Met in several processes of development, the mechanisms involving Met in resistance to current therapies or the likely emergence of resistances to Met-targeted therapies.

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20143010013DOI Listing
October 2014
8 Reads

Publication Analysis

Top Keywords

met receptor
12
resistance current
8
current therapies
8
met
8
data pharmaceutical
4
based data
4
therapies deciphered
4
therapies
4
pharmaceutical companies
4
deciphered based
4
developed variety
4
evaluated phase iii
4
phase iii clinical
4
inhibitors evaluated
4
met inhibitors
4
variety met
4
companies developed
4
met involvement
4
signaling network
4
network parallel
4

References

(Supplied by CrossRef)

Cooper et al.
Nature 1984

Nakamura et al.
Biochem Biophys Res Commun 1984

Stoker et al.
Nature 1987

Weidner et al.
Proc Natl Acad Sci USA 1991

Gherardi et al.
Nat Rev Cancer 2012

Gherardi et al.
Proc Natl Acad Sci USA 2003

Schiering et al.
Proc Natl Acad Sci USA 2003

Gherardi et al.
Proc Natl Acad Sci USA 2006

Andermarcher et al.
Dev Genet 1996

Uehara et al.
Nature 1995

Schmidt et al.
Nature 1995

Similar Publications